Examkin

Soru

Zorluk: Çok zorSchizophrenia and Psychotic Disorders

A young adult with previously undiagnosed psychiatric illness presents to emergency services exhibiting profound psychomotor agitation, persecutory delusions, and command hallucinations. Over the next two years, his condition proves exceptionally difficult to manage, eventually resulting in a life-threatening pharmacological complication. Based on established psychiatric guidelines, arrange the following clinical interventions in the chronological order they would be correctly implemented for this patient's evolving clinical course.

  1. 1Employ verbal de-escalation techniques and transition the patient to a low-stimulus environment
  2. 2Administer a combination of intramuscular haloperidol, lorazepam, and benztropine
  3. 3Initiate a scheduled regimen of oral risperidone and evaluate therapeutic efficacy over a 4-to-6-week period
  4. 4Prescribe clozapine with mandatory enrollment in a Risk Evaluation and Mitigation Strategy (REMS) program
  5. 5Immediately discontinue psychotropic agents and obtain a stat absolute neutrophil count

Cevap

The correct sequence begins with non-pharmacological de-escalation, followed by intramuscular agents for failed de-escalation, then a first-line oral antipsychotic trial, progressing to clozapine for treatment resistance, and finally stopping the agent to check the absolute neutrophil count for clozapine-induced agranulocytosis.
The algorithmic approach to schizophrenia begins with the least restrictive means to control acute agitation (environmental and verbal de-escalation), escalating to chemical restraints (IM haloperidol/lorazepam) only if unsuccessful. Once the acute crisis is stabilized, first-line long-term maintenance requires a full 4-to-6-week trial of an oral second-generation antipsychotic (e.g., risperidone). Treatment-resistant schizophrenia is formally diagnosed only after two failed adequate trials, which then strongly indicates the initiation of clozapine. Finally, a known, life-threatening complication of clozapine therapy is agranulocytosis; any signs of systemic infection require immediate drug cessation and absolute neutrophil count (ANC) testing.

Adım Adım Çözüm

1
Address acute agitation using the least restrictive means.
Employ verbal de-escalation techniques and transition the patient to a low-stimulus environment.
Current psychiatric guidelines mandate attempting non-pharmacological interventions first to preserve patient autonomy and avoid medication side effects.
2
Utilize chemical restraint for severe, refractory agitation.
Administer a combination of intramuscular haloperidol, lorazepam, and benztropine.
When verbal de-escalation fails and the patient poses an imminent risk, IM high-potency antipsychotics and benzodiazepines are required. Benztropine prevents acute dystonia.
3
Establish a baseline maintenance therapy.
Initiate a scheduled regimen of oral risperidone and evaluate therapeutic efficacy over a 4-to-6-week period.
Following stabilization, a newly diagnosed patient should undergo a 4-to-6-week trial of a first-line oral second-generation antipsychotic.
4
Manage treatment-resistant schizophrenia.
Prescribe clozapine with mandatory enrollment in a Risk Evaluation and Mitigation Strategy (REMS) program.
Failure of the initial risperidone trial and a subsequent trial confirms treatment-resistant schizophrenia, which is the primary indication for clozapine.
5
Address severe clozapine-associated adverse effects.
Immediately discontinue psychotropic agents and obtain a stat absolute neutrophil count.
A life-threatening complication of clozapine is agranulocytosis. The sudden onset of infectious symptoms requires immediate cessation of the drug and evaluation of the ANC.

Anahtar Kavram

Algorithmic stepwise management of schizophrenia from acute agitation to treatment resistance and the management of severe pharmacologic complications.
Tahmini Süre:2m 0s
Bu soruyu puanla

Konular

Schizophrenia and Psychotic Disorders

Bu konudan daha fazla soru